|
市場調査レポート
商品コード
1390485
腸溶性ソフトジェルカプセルの市場レポート:タイプ、用途、流通チャネル、地域別、2023-2028年Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
腸溶性ソフトジェルカプセルの市場レポート:タイプ、用途、流通チャネル、地域別、2023-2028年 |
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
腸溶性ソフトジェルカプセルの世界市場規模は2022年に25億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに32億米ドルに達し、2022~2028年の成長率(CAGR)は4.20%になると予測しています。
腸溶性ソフトジェルカプセルは、ゼラチンをベースとしたシェルコーティングが施され、内部に半固形および液体の薬剤が入っています。消化液に対する耐性があるため、胃を通過しても影響を受けず、腸管で溶解します。バイオアベイラビリティ、使いやすさ、適正レベルの向上など、いくつかの利点があります。その上、後味の悪さを最小限に抑え、投与効率を最適化し、消化不良の治療に役立ち、胃の炎症や逆流を防ぐ。現在、予防薬を摂取することの利点に関する個人の意識の高まりが、腸溶性ソフトジェルカプセルの需要を世界的に刺激しています。
世界の老人人口の増加、慢性疾患や栄養不足の病気の有病率の上昇は、市場にプラスの影響を与える主な要因の1つです。さらに、個人間の健康意識の高まりと栄養補助食品の受け入れ拡大が、世界中で腸溶性ソフトジェルカプセルの需要を刺激しています。これに加えて、製薬業界における著しい成長と、オメガ3系オイルやその他のゲルベースのサプリメントを封入する製品の用途拡大が、有利な市場見通しを提供しています。さらに、非ゼラチンベースの腸溶性ソフトジェルカプセルのイントロダクションのような製品の革新は、市場の成長を強化しています。さらに、大手企業は、菜食主義者の消費者の要求に応えるため、デンプンやその他の有機植物由来原料を使用した新規製品の製造に注力しています。さらに、薬局の拡大やeコマース小売チャネルを通じたオンライン薬局の普及が、市場に明るい見通しをもたらしています。さらに、これらのカプセルのバイオアベイラビリティを改善するための研究開発(R&D)活動に対する大手製薬会社の投資の増加は、市場の成長を促進すると予想されます。
The global enteric softgel capsules market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.20% during 2022-2028.
Enteric softgel capsules have gelatin-based shell coating with semi-solid and liquid medication inside. They are resistant to digestive juices and consequently pass through the stomach unaffected and dissolve in the intestinal tract. They provide several advantages, such as bioavailability, easy usability, and improved adequacy levels. Besides this, they minimize poor aftertaste, optimize dosage efficiency, help treat indigestion, and prevent gastric irritation and reflux. Presently, the increasing awareness among individuals about the benefits of consuming preventive medicines is catalyzing the demand for enteric softgel capsules worldwide.
The growing global geriatric population, along with the rising prevalence of chronic medical disorders and nutrient-deficient diseases, represents one of the key factors positively influencing the market. In addition, the rising health awareness among individuals and the growing acceptance of nutritional and dietary supplements are catalyzing the demand for enteric softgel capsules across the globe. Besides this, significant growth in the pharmaceutical industry and the expanding applications of the product to enclose omega-3 oils and other gel-based supplements are offering a favorable market outlook. Additionally, product innovations like the introduction of non-gelatin-based enteric softgel capsules are strengthening the growth of the market. In addition, leading players are focusing on manufacturing novel variants by using starch and other organic, plant-based sources to meet the requirements of vegan consumers. Furthermore, the growing expansion of pharmacies and the proliferation of online pharmacies through e-commerce retail channels are creating a positive outlook for the market. Moreover, increasing investments by leading pharma companies in research and development (R&D) activities to improve the bioavailability of these capsules are expected to propel market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteric softgel capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and distribution channel.
Gelatin Capsules
Non-Gelatin Softgel Capsules
Gelatin capsules currently represent the largest market segment due to the increasing vegan population across the globe.
Health Supplements
Pharmaceuticals
Health supplements hold the majority of the global enteric softgel capsules market share due to the increasing usage of softgel capsules by fitness enthusiasts and rising awareness among individuals about nutraceutical supplements.
Supermarkets and Hypermarkets
Pharmacy and Drug Stores
Online Stores
Pharmacy and drug stores presently dominate the market on account of the increasing consumer preference to purchase medicinal products from registered pharmacies or drug stores.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market as healthcare providers are increasingly investing in research and development (R&D) activities to introduce effective treatment alternatives.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.